151 related articles for article (PubMed ID: 29744807)
1. Dysplastic features seen in a patient with acute myeloid leukemia harboring the KTM2A-TET1 fusion gene.
Kawai H; Matsushita H; Aoyama Y; Matsui K; Onizuka M; Ando K
Int J Hematol; 2018 Jul; 108(1):1-2. PubMed ID: 29744807
[No Abstract] [Full Text] [Related]
2. MLL-TET1 fusion protein promotes immortalization of myeloid progenitor cells and leukemia development.
Kim HS; Oh SH; Kim JH; Kim JY; Kim DH; Lee SJ; Choi SU; Park KM; Ryoo ZY; Park TS; Lee S
Haematologica; 2017 Nov; 102(11):e434-e437. PubMed ID: 28798069
[No Abstract] [Full Text] [Related]
3. Identification of MLL-fusion/MYC⊣miR-26⊣TET1 signaling circuit in MLL-rearranged leukemia.
Huang H; Jiang X; Wang J; Li Y; Song CX; Chen P; Li S; Gurbuxani S; Arnovitz S; Wang Y; Weng H; Neilly MB; He C; Li Z; Chen J
Cancer Lett; 2016 Mar; 372(2):157-65. PubMed ID: 26791235
[TBL] [Abstract][Full Text] [Related]
4. RNA sequencing reveals a unique fusion of the lysine (K)-specific methyltransferase 2A and smooth muscle myosin heavy chain 11 in myelodysplastic syndrome and acute myeloid leukemia.
Sanders MA; Kavelaars FG; Zeilemaker A; Al Hinai AS; Abbas S; Beverloo HB; van Lom K; Valk PJ
Haematologica; 2015 Jan; 100(1):e1-3. PubMed ID: 25552680
[No Abstract] [Full Text] [Related]
5. Identification of enhancer of mRNA decapping 4 as a novel fusion partner of
Becker H; Greve G; Kataoka K; Mallm JP; Duque-Afonso J; Ma T; Niemöller C; Pantic M; Duyster J; Cleary ML; Schüler J; Rippe K; Ogawa S; Lübbert M
Blood Adv; 2019 Mar; 3(5):761-765. PubMed ID: 30833276
[TBL] [Abstract][Full Text] [Related]
6. Mixed-phenotype acute leukemia with t(4;11)(q21;q23)
Liu H
Blood; 2019 Mar; 133(11):1265. PubMed ID: 30872272
[No Abstract] [Full Text] [Related]
7. A novel KMT2A-USO1 fusion gene-induced de novo secondary acute myeloid leukaemia in a patient initially diagnosed with acute promyelocytic leukaemia.
Jin W; Chen L; Liu Y; Chen Q; Zhao M; Tan Y; Zhang W; Song H; Weng X; Mi J; Chen S; Chen Z; Li J; Wang K
Br J Haematol; 2021 Jan; 192(1):e32-e36. PubMed ID: 33216970
[No Abstract] [Full Text] [Related]
8. miR-101 suppresses the development of
Gonzales-Aloy E; Connerty P; Salik B; Liu B; Woo AJ; Haber M; Norris MD; Wang J; Wang JY
Haematologica; 2019 Jul; 104(7):e296-e299. PubMed ID: 30792205
[No Abstract] [Full Text] [Related]
9. Molecular characterization of KMT2A fusion partner genes in 13 cases of pediatric leukemia with complex or cryptic karyotypes.
Ney Garcia DR; de Souza MT; de Figueiredo AF; Othman MAK; Rittscher K; Abdelhay E; Capela de Matos RR; Meyer C; Marschalek R; Land MGP; Liehr T; Ribeiro RC; Silva MLM
Hematol Oncol; 2017 Dec; 35(4):760-768. PubMed ID: 27282883
[TBL] [Abstract][Full Text] [Related]
10. Acquired persistently complete remission by decitabine-based treatment for acute myeloid leukemia with the
Wang F; Chen Y; Jiang N; Gong S; Cao T; Yuan J; Liu J; Xie L; Wu Y; Jia Y
Leuk Lymphoma; 2019 Dec; 60(13):3304-3307. PubMed ID: 31256701
[No Abstract] [Full Text] [Related]
11. Hyperdiploidy and duplication of der(11)ins(10;11)(p12;q23q14) in acute myeloid leukemia with MLL/MLLT10 fusion gene.
Yamamoto K; Yakushijin K; Okamura A; Ueda S; Nakamachi Y; Kawano S; Matsuoka H; Minami H
Leuk Lymphoma; 2013 Sep; 54(9):2055-8. PubMed ID: 23278644
[No Abstract] [Full Text] [Related]
12. Identification of Mixed Lineage Leukemia Gene (MLL)/MLLT10 Fusion Transcripts by Reverse Transcription-PCR and Sequencing in a Case of AML With a FISH-Negative Cryptic MLL Rearrangement.
Ko K; Kwon MJ; Woo HY; Park H; Park CH; Lee ST; Kim SH
Ann Lab Med; 2015 Jul; 35(4):469-71. PubMed ID: 26131423
[No Abstract] [Full Text] [Related]
13. TOP3A, a new partner gene fused to MLL in an adult patient with de novo acute myeloid leukaemia.
Herbaux C; Poulain S; Meyer C; Marschalek R; Renneville A; Fernandes J; Theisen O; Tricot S; Simon M; Duthilleul P; Daudignon A
Br J Haematol; 2012 Apr; 157(1):128-31. PubMed ID: 22050635
[No Abstract] [Full Text] [Related]
14. Genomic breakpoints and clinical features of MLL-TET1 rearrangement in acute leukemias.
Lee SG; Cho SY; Kim MJ; Oh SH; Cho EH; Lee S; Baek EJ; Choi JH; Bohlander SK; Lode L; Richebourg S; Yoon HJ; Marschalek R; Meyer C; Park TS
Haematologica; 2013 Apr; 98(4):e55-7. PubMed ID: 23100278
[No Abstract] [Full Text] [Related]
15. Cryptic t(6;11) KMT2A rearrangement in a pediatric acute myeloid leukemia patient detected by next-generation sequencing and dual-fusion FISH analysis.
Raghunandan S; Jain J; Saxe D; Pauly M; Aljudi AA; Ketterling RP; Carter AB; Raikar SS
Pediatr Blood Cancer; 2022 Mar; 69(3):e29428. PubMed ID: 34766724
[No Abstract] [Full Text] [Related]
16. De novo acute myeloid leukemia associated with t(11;17)(q23;q25) and MLL-SEPT9 rearrangement in an elderly patient: a case study and review of the literature.
Lee SG; Park TS; Oh SH; Park JC; Yang YJ; Marschalek R; Meyer C; Cho EH; Shin SY
Acta Haematol; 2011; 126(4):195-8. PubMed ID: 21846973
[No Abstract] [Full Text] [Related]
17. Acute leukemias harboring KMT2A/MLLT10 fusion: a 10-year experience from a single genomics laboratory.
Peterson JF; Sukov WR; Pitel BA; Smoley SA; Pearce KE; Meyer RG; Williamson CM; Smadbeck JB; Vasmatzis G; Hoppman NL; Greipp PT; Baughn LB; Ketterling RP
Genes Chromosomes Cancer; 2019 Aug; 58(8):567-577. PubMed ID: 30707474
[TBL] [Abstract][Full Text] [Related]
18. TET1, a member of a novel protein family, is fused to MLL in acute myeloid leukemia containing the t(10;11)(q22;q23).
Lorsbach RB; Moore J; Mathew S; Raimondi SC; Mukatira ST; Downing JR
Leukemia; 2003 Mar; 17(3):637-41. PubMed ID: 12646957
[No Abstract] [Full Text] [Related]
19. First description of the t(10;11)(q22;q23)/MLL-TET1 translocation in a T-cell lymphoblastic lymphoma, with subsequent lineage switch to acute myelomonocytic myeloid leukemia.
Ittel A; Jeandidier E; Helias C; Perrusson N; Humbrecht C; Lioure B; Mazurier I; Mayeur-Rousse C; Lavaux A; Thiebault S; Lerintiu F; Gervais C; Mauvieux L
Haematologica; 2013 Dec; 98(12):e166-8. PubMed ID: 24323992
[No Abstract] [Full Text] [Related]
20. The CDK9 Inhibitor Dinaciclib Exerts Potent Apoptotic and Antitumor Effects in Preclinical Models of MLL-Rearranged Acute Myeloid Leukemia.
Baker A; Gregory GP; Verbrugge I; Kats L; Hilton JJ; Vidacs E; Lee EM; Lock RB; Zuber J; Shortt J; Johnstone RW
Cancer Res; 2016 Mar; 76(5):1158-69. PubMed ID: 26627013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
